BLRX - BioLineRx's (BLRX) CEO Phil Serlin on Q3 2020 Results - Earnings Call Transcript

BioLineRx Ltd. (BLRX) Q3 2020 Earnings Conference Call November 23, 2020 10:00 AM ET Company Participants Timothy McCarthy – LifeSci Advisors, LLC Phil Serlin – Chief Executive Officer Mali Zeevi – Chief Financial Officer Abi Vainstein – Vice President-Clinical Development Conference Call Participants Joe Pantginis – HC Wainwright Mark Breidenbach – Oppenheimer Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Third Quarter 2020 Results Conference Call. All participants are present in a listen-only mode. [Operator Instructions] I would now like to turn the call over to Timothy McCarthy of LifeSci Advisors to read the Safe Harbor statement. Tim, please go ahead. Timothy McCarthy Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements in this conference call, other than historical facts, are indeed forward-looking statements. The words anticipate, believe, estimate, expect,

For further details see:

BioLineRx's (BLRX) CEO Phil Serlin on Q3 2020 Results - Earnings Call Transcript